Patents by Inventor Shuichi Asakawa

Shuichi Asakawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antitumor peptide and use thereof
    Patent number: 11472845
    Abstract: A synthetic peptide provided by the present invention includes: (1) a CTLA4-SP-related sequence; and (2) an amino acid sequence that functions as a cell penetrating peptide, wherein the synthetic peptide has a total number of amino acid residues of 100 or less.
    Type: Grant
    Filed: October 8, 2020
    Date of Patent: October 18, 2022
    Assignees: TOAGOSEI CO., LTD, The University of Tokyo
    Inventors: Nahoko Baileykobayashi, Tetsuhiko Yoshida, Shuichi Asakawa
  • ANTITUMOR PEPTIDE AND USE THEREOF
    Publication number: 20210115089
    Abstract: A synthetic peptide provided by the present invention includes: (1) a CTLA4-SP-related sequence; and (2) an amino acid sequence that functions as a cell penetrating peptide, wherein the synthetic peptide has a total number of amino acid residues of 100 or less.
    Type: Application
    Filed: October 8, 2020
    Publication date: April 22, 2021
    Inventors: Nahoko Baileykobayashi, Tetsuhiko Yoshida, Shuichi Asakawa
  • Digital correlation of test samples and the screening of interactions between the same
    Patent number: 6662113
    Abstract: A method for determining the physical, chemical, or biological correlation between test samples in group A and test samples in group B. This correlation can be determined by contacting a mixture of test samples selected according to a certain rule from group A with test samples from group B to detect the interaction(s) between them. The number of reactions needed to detect these interaction(s) is greatly reduced by preparing a mixture of test samples in group A according to the principle of binary notation, and thus enables a rapid screening.
    Type: Grant
    Filed: November 23, 1999
    Date of Patent: December 9, 2003
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Nobuyoshi Shimizu, Shuichi Asakawa